A Phase 3, Open-Label, 1-Year Study Of The Safety, Tolerability, And Need For Re-Treatment With Sage-217 In Adult Subjects With Major Depressive Disorder
Posted Date: Jan 25, 2021
- Investigator: Caleb Adler
- Specialties: Depression, Psychiatry/Psychology
- Type of Study: Drug
This study is to determine the safety and tolerability of initial treatment and/or re-treatment(s) in adults with MDD experiencing a major depressive episode (MDE) .
Criteria:
Adults With Mdd Experiencing A Major Depressive Episode.
Keywords:
Depression, Mdd, Adults
For More Information:
Emily Rummelhoff
513-558-4295
emily.rummelhoff@uc.edu